Skip to main content
Transparency

Editorial Policy

How we source, verify, and present information on MyopiaProgression.com. Our commitment to accuracy, transparency, and evidence-based guidance.

Our Mission

MyopiaProgression.com exists to provide parents, eye care professionals, students, and researchers with accurate, evidence-based information about childhood myopia and its management. We are committed to presenting complex medical information in an accessible way while maintaining scientific rigor.

We are not a medical provider. The information on this site is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

How We Source Information

Primary Sources

  • 1.Peer-reviewed research published in journals indexed by PubMed, including Ophthalmology, JAMA Ophthalmology, and Investigative Ophthalmology & Visual Science.
  • 2.Government health agencies including the FDA, NIH/NEI, CDC, and equivalent international bodies.
  • 3.Professional organizations such as the American Academy of Ophthalmology (AAO), American Optometric Association (AOA), and International Myopia Institute (IMI).
  • 4.Clinical trial registries including ClinicalTrials.gov for ongoing and completed studies.

We prioritize systematic reviews, meta-analyses, and randomized controlled trials when available. When citing individual studies, we note sample size, study design, and limitations.

FDA Status Clarity

We are careful to distinguish between different regulatory statuses:

Section Content

FDA-Approved for Myopia Control

Products that have received specific FDA approval for slowing myopia progression (e.g., MiSight 1 day contact lenses, approved November 2019).

FDA-Cleared / Evidence-Supported

Products FDA-cleared for vision correction that have clinical evidence supporting myopia control benefits, but are not FDA-indicated for that purpose (e.g., Ortho-K lenses).

Off-Label / Prescription Option

Treatments prescribed by doctors based on clinical evidence but not FDA-approved specifically for myopia control (e.g., low-dose atropine drops).

Editorial Review Process

  1. 1
    Research & Drafting

    Content is researched and drafted by writers with science or health communication backgrounds.

  2. 2
    Fact-Checking

    All claims are verified against primary sources. Statistics include source citations.

  3. 3
    Medical Review

    Clinical content is reviewed by eye care professionals (OD or MD) for accuracy.

  4. 4
    Regular Updates

    Content is reviewed periodically and updated when new research or guidelines emerge.

Conflict of Interest Disclosure

MyopiaProgression.com may receive revenue from:

  • Provider directory listings (Featured Listings)
  • Embedded tools licensed to eye care practices
  • Affiliate relationships (clearly disclosed when applicable)

Editorial independence: Our editorial content is never influenced by commercial relationships. Treatment comparisons and recommendations are based solely on published evidence and clinical guidelines.

Questions or Corrections?

If you believe any information on our site is inaccurate or outdated, please contact us. We take corrections seriously and will investigate promptly.

[email protected]
For Parents

Worried your child's myopia (nearsightedness) is getting worse?

Take the 2–3 minute risk assessment and get a clear next step.

For Providers

Eye doctor?

Join our network where parents search for myopia specialists.

Pre-launch: secure your placement now.

Free Download
5 Signs Your Child Needs Myopia Control

5 Signs Your Child Needs Myopia Control

A quick-start guide for concerned parents. Learn when to take action.